World Health Organization et al., 2019-04-05: WHO's prequalification record shows mebendazole 500 mg chewable tablets from Janssen-Cilag prequalified on 5 April 2019, with the finished product made by Lusomedicamenta in Portugal and the active ingredient sourced from two Chinese API plants.
Date of prequalification 5 Apr, 2019
World Health Organization et al., 2019-04-05: WHO's prequalification record shows mebendazole 500 mg chewable tablets from Janssen-Cilag prequalified on 5 April 2019, with the finished product made by Lusomedicamenta in Portugal and the active ingredient sourced from two Chinese API plants. Record-field transcription of the WHO PQ database entry (not prose), access date 2026-11-19. Fields also recorded on the page: API manufacturing sites Changzhou Yabang-QH Pharmachem Co Ltd (Changzhou, Jiangsu, China) and Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. (Hanzhong, Shaanxi, China); FPP manufacturing site Lusomedicamenta Sociedade Tecnica Farmaceutica S.A., Barcarena, Portugal; HDPE bottle, 200×1, shelf life 60 months, storage not above 30 C; status Prequalified. This is the only mebendazole product on the WHO PQ list at the access date. Study type: regulatory record.
